Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000075144 | SCV000106134 | pathogenic | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | Coding sequence variation resulting in a stop codon |
Labcorp Genetics |
RCV001034673 | SCV000253785 | pathogenic | Hereditary nonpolyposis colorectal neoplasms | 2022-10-17 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 89672). This premature translational stop signal has been observed in individual(s) with lynch syndrome (PMID: 21642682). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln391*) in the MLH1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MLH1 are known to be pathogenic (PMID: 15713769, 24362816). |
MGZ Medical Genetics Center | RCV002288566 | SCV002579739 | pathogenic | Colorectal cancer, hereditary nonpolyposis, type 2 | 2022-07-12 | criteria provided, single submitter | clinical testing | |
Human Genetics Bochum, |
RCV002288566 | SCV002758593 | pathogenic | Colorectal cancer, hereditary nonpolyposis, type 2 | 2022-05-24 | criteria provided, single submitter | clinical testing | ACMG criteria used to clasify this variant: PVS1, PM2, PS4 |